← Compound index
COMPOUND RECORD / THYMOHEXIN

ThymohexinТимогексин

An experimental synthetic hexapeptide studied for effects on blood-cell formation after irradiation. Historical sources disagree on whether one residue is aspartate or asparagine, leaving the exact sequence unresolved.

Source linked

What the studies found

Animal research · 1993

[Radioprotective effect of synthetic immunomodulators on hemopoietic CFU-S].

Study of multiple preparations

Spleen hematopoietic colony-forming units (CFU-S)
Both peptides reportedly halved the measured radiation-related loss of CFU-S in the experimental comparison.
Post-exposure recovery
The abstract describes greater CFU-S recovery than in controls in a separate comparison.

Synthetic peptides were studied using hematopoietic colony assays after irradiation. The indexed abstract gives Thymohexin as Arg–Lys–Asp–Val–Tyr–Arg; the conflicting Asn/RKNVYR rendering requires checking against original chemistry.

Study notes · methods, sources and limitations

Participants or model See original report; human, animal and laboratory components must be distinguished.

Design Mouse hematopoietic colony assay after irradiation. Group sizes and treatment doses were unavailable in the abstract.

Important limitations

  • The abstract leaves the preparation and study methods unclear. Related publications may share experiments; source count is not independent-study count.
  • A laboratory endpoint in mice. The finding does not establish clinical radioprotection.

Radiatsionnaia biologiia, radioecologiia · Indexed abstract

Original source or citation ↗

Study results and tables ↗
01 / OVERVIEW

About Thymohexin

Research background

Synthetic hexapeptide investigated in radiation-related hematopoietic models. Original sequence verification is needed because Asp and Asn renderings conflict.

Compound class
Peptide / preparation research
Research collection
Peptide bioregulation · editorial grouping
Institutions in linked studies
See individual study records
Source review
Review dates and the material assessed are listed with each publication below.
02 / HOW TO READ THE RESEARCH

Understanding the evidence

Human research

See preparation-specific records; human benefit not established here

Study methods

Source-specific designs and limitations below

Independent replication

Related reports are not automatically independent evidence

Source access

Linked publications; access and review scope shown per record

Safety evidence

Clinical safety, product equivalence and interactions not established by this collection

Open a topic for the evidence assessment.

More findings, background and history
RELATED PEPTIDE RESEARCH / UPDATED OCTOBER 2026

Connections in the research

The 2020 Imunofan paper uses RDKVYR and also calls it Thymohexin. The earlier indexed record spells RKDVYR. These Asp/Lys positions differ; the new source is linked as a nomenclature comparison, not proof that the preparations are identical.

View the peptide family map and sources ↗

What remains unclear

The available experimental studies leave human benefit and safety uncertain.

No human intervention report has been identified among the linked records; unclassified archival leads may remain. Several publications can describe the same participants.

Browse original study records ↗

Explore the expanded peptide research collection and unresolved source trails ↗

03 / SOURCE RECORDS

Findings by study

Explore related research ↗

Animal research · 1993

[Radioprotective effect of synthetic immunomodulators on hemopoietic CFU-S].

Synthetic peptides were studied using hematopoietic colony assays after irradiation. The indexed abstract gives Thymohexin as Arg–Lys–Asp–Val–Tyr–Arg; the conflicting Asn/RKNVYR rendering requires checking against original chemistry.

Study notes and original source
1993Animal / experimentalEnglish abstract

[Radioprotective effect of synthetic immunomodulators on hemopoietic CFU-S].

Preparation-specific research; no equivalence inferred

Sëmina OV, Semenets TN, Deĭgin VI, Korotkov AM, Poverennyĭ AM. · Radiatsionnaia biologiia, radioecologiia

Synthetic peptides were studied using hematopoietic colony assays after irradiation. The indexed abstract gives Thymohexin as Arg–Lys–Asp–Val–Tyr–Arg; the conflicting Asn/RKNVYR rendering requires checking against original chemistry.

Results and tables

Reported findings and study design

Mouse hematopoietic colony assay after irradiation. Group sizes and treatment doses were unavailable in the abstract.

Results · Original indexed abstract
MeasureResultComparison, timing and statistics
Spleen hematopoietic colony-forming units (CFU-S)Both peptides reportedly halved the measured radiation-related loss of CFU-S in the experimental comparison.
Post-exposure recoveryThe abstract describes greater CFU-S recovery than in controls in a separate comparison.

A laboratory endpoint in mice. The finding does not establish clinical radioprotection.

Source for these results ↗ · Reviewed 2026-11-10

Population / setting
See original report; human, animal and laboratory components must be distinguished.
Source reviewed
Indexed metadata and abstract checked via Europe PMC. Original full methods not reviewed.
Study limitations
  • The abstract leaves the preparation and study methods unclear.
  • Related publications may share experiments; source count is not independent-study count.

Reviewed 2026-10-02.

Read the source ↗

Follow shared publications or research classes. These links do not establish equivalent effects between compounds.

Research collection curated by @PepMariner · editorial standards. Send a source correction ↗

Browse bibliography & PDFs ↗